Guadalupe Tirma Gónzalez-Mateo

Author

Centro de Biología Molecular Severo Ochoa ORCID

Also Known As

G T González-Mateo, G. Gonzalez-Mateo, G. González-Mateo, G. T. Gonzalez-Mateo, Guadalupe Gonzalez-Mateo, Guadalupe González Mateo, Guadalupe González-Mateo, Guadalupe Gónzalez-Mateo, Guadalupe T González-Mateo, Guadalupe T González‐Mateo

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Centro de Biología Molecular Severo Ochoa Universidad Autónoma de Madrid Hospital Universitario La Paz Hospital Universitario de La Princesa Hospital Universitario Fundación Jiménez Díaz

About

Guadalupe Tirma Gónzalez-Mateo is an author at Centro de Biología Molecular Severo Ochoa specializing in medicine, immunology, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	433
2	Cell Biology	2	2	91
3	Health Sciences	1	1	67
4	Natural Sciences	1	1	30
5	Biochemistry	1	1	30

Guadalupe Tirma Gónzalez-Mateo

Publications

797

Citations

H-Index

Page 1

	Year	Citations
BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure Jesús Loureiro, Margot N. Schilte, Abelardo Aguilera, Nephrology Dialysis Transplantation	2010	101
IL-17A is a novel player in dialysis-induced peritoneal damage Raquel Rodrigues‐Díez, Luiz Stark Aroeira, Macarena Orejudo, Kidney International InflammationHemodialysisUrologyMedicineKidney Failure	2014	84
Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid M. Auxiliadora Bajo, Marı́a Luisa Lozano, Patricia Albar-Vizcaíno, Nephrology Dialysis Transplantation	2010	84
PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage Pilar Sandoval, Jesús Loureiro, Guadalupe Tirma Gónzalez-Mateo, Laboratory Investigation HemodialysisMedicinePhysiologyDialysis TherapyPpar-γ Agonist Rosiglitazone	2010	68
Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis Jesús Loureiro, Pilar Sandoval, Gloria del Peso, PLoS ONE Tissue EngineeringImmunologyImmune RegulationRegenerative MedicineTissue Development	2013	67
Paricalcitol Reduces Peritoneal Fibrosis in Mice through the Activation of Regulatory T Cells and Reduction in IL-17 Production Guadalupe Tirma Gónzalez-Mateo, Vanessa Fernández-Míllara, Teresa Bellón, PLoS ONE Chronic Inflammatory DiseasesImmune RegulationImmunologyPathologyRegulatory T Cells	2014	58
Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients Vicente Ruiz‐Carpio, Pilar Sandoval, Abelardo Aguilera, Scientific Reports	2017	43
Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution–induced fibrosis Anne‐Catherine Raby, Guadalupe Tirma Gónzalez-Mateo, A. Williams, Kidney International InflammationToll-like ReceptorsPrevents Peritoneal DialysisFibrosisDialysis	2018	40
Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis Georgios Liappas, Guadalupe Tirma Gónzalez-Mateo, Raquel Sánchez‐Díaz, Journal of the American Society of Nephrology	2016	38
Lithium preserves peritoneal membrane integrity by suppressing mesothelial cell αB-crystallin Rebecca Herzog, Juan Manuel Sacnun, Guadalupe Tirma Gónzalez-Mateo, Science Translational Medicine	2021	33

Page 1